Patents by Inventor Emery Dora

Emery Dora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC ADENOVIRAL VECTORS
    Publication number: 20240093234
    Abstract: The present disclosure provides expression vectors, e.g., chimeric adenoviral vectors, comprising a nucleic acid encoding a coronavirus disease 2019 (COVID-19) N protein, e.g., an N protein from SARS-CoV-2, and a heterologous antigenic polypeptide and methods employing such expression vectors for using the vectors to elicit an immune response.
    Type: Application
    Filed: January 31, 2022
    Publication date: March 21, 2024
    Inventors: Sean Tucker, Emery Dora
  • CHIMERIC ADENOVIRAL VECTORS
    Publication number: 20230210980
    Abstract: The present disclosure provides chimeric adenoviral vectors comprising a nucleic acid encoding a coronavirus disease 2019 (COVID-19) protein and an adjuvant and methods for using the vectors to elicit an immune response to the SARS-CoV-2 protein in order to treat COVID-19.
    Type: Application
    Filed: June 4, 2021
    Publication date: July 6, 2023
    Inventors: Sean Tucker, Emery Dora
  • Flj10607 as modifier of the axin pathway and methods of use
    Publication number: 20070141648
    Abstract: Human FLJ10607 genes are identified as modulators of the Axin pathway, and thus are therapeutic targets for disorders associated with defective Axin function. Methods for identifying modulators of Axin, comprising screening for agents that modulate the activity of FLJ10607 are provided.
    Type: Application
    Filed: December 29, 2003
    Publication date: June 21, 2007
    Inventors: Steven Gendreau, Emery Dora, Kim Lickteig
  • Maxs as modifiers of the axin pathway and methods of use
    Publication number: 20050266406
    Abstract: Human MAX genes are identified as modulators of the AXIN pathway, and thus are therapeutic targets for disorders associated with defective AXIN function. Methods for identifying modulators of AXIN, comprising screening for agents that modulate the activity of MAX are provided.
    Type: Application
    Filed: August 6, 2003
    Publication date: December 1, 2005
    Inventors: Steve Gendreau, Emery Dora, Kim Lickteig, Craig Amundsen
  • Pappss as modifiers of the axin pathway and methods of use
    Publication number: 20050176013
    Abstract: Human PAPSS genes are identified as modulators of the AXIN pathway, and thus are therapeutic targets for disorders associated with defective AXIN function. Methods for identifying modulators of AXIN, comprising screening for agents that modulate the activity of PAPSS are provided.
    Type: Application
    Filed: August 6, 2003
    Publication date: August 11, 2005
    Inventors: Steven Gendreau, Emery Dora, Kim Lickteig